Dexamethasone for treatment of severe COVID-19, a surprise?

[...]the Surviving Sepsis Campaign panel recently recommended that “mechanically ventilated patients with COVID-19 related ARDS should be managed similarly to other patients with acute respiratory failure in the ICU” [3]. [...]Villar and his colleagues have published the largest meta-analysis of usi...

Full description

Saved in:
Bibliographic Details
Published in:Cardiothoracic Surgeon 2020-09, Vol.28 (1), p.22-2, Article 22
Main Author: Elsayed, Hany Hasan
Format: Article
Language:English
Subjects:
ARDS
Central nervous system depressants
Coronaviruses
COVID-19
Dexamethasone
Drug dosages
Intensive care
Letter to the Editor
Medicine
Medicine & Public Health
Mortality
Patients
Pneumonia
Respiratory distress syndrome
Sepsis
Steroids
Ventilators
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[...]the Surviving Sepsis Campaign panel recently recommended that “mechanically ventilated patients with COVID-19 related ARDS should be managed similarly to other patients with acute respiratory failure in the ICU” [3]. [...]Villar and his colleagues have published the largest meta-analysis of using dexamethasone treatment for the acute respiratory distress syndrome few months back and this has shown a mortality benefit [6]. [...]1772 patients with severe COVID-19 ARDS requiring mechanical ventilation in the RECOVERY trial did not receive steroids.
ISSN:2662-2203
2636-333X
2662-2203
DOI:10.1186/s43057-020-00032-1